Literature DB >> 18595861

Behavioral and complementary approaches for the treatment of irritable bowel syndrome.

Arnold Wald1, David Rakel.   

Abstract

Irritable bowel syndrome (IBS) is one of the most common conditions seen in primary care settings. Despite this, there is no consensus as to the pathogenesis of this disorder or a consistently effective therapeutic regimen for many patients. This has encouraged the use of various alternative therapies from behavioral or complementary medicine. This review will address the evidence for alternative therapies, including the following: cognitive behavior therapy, hypnosis, elimination diets based on food antibody testing, nutrition supplements (such as fiber, probiotics, and prebiotics), and, finally, peppermint, l-glutamine, zinc, and cromolyn sodium. The review also explores the evidence for and the therapeutic ramifications of the hypothesis that increased intestinal permeability underlies the symptoms of IBS in many patients, and how a therapeutic plan that addresses nutrition, elimination diets, and nutrition supplements may be useful in restoring the integrity of the gut immune barrier.

Entities:  

Mesh:

Year:  2008        PMID: 18595861     DOI: 10.1177/0884533608318677

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  11 in total

Review 1.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 2.  Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity.

Authors:  Pasquale Mansueto; Alberto D'Alcamo; Aurelio Seidita; Antonio Carroccio
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

3.  Nutritional status in irritable bowel syndrome: A North American population-based study.

Authors:  Isabel A Hujoel
Journal:  JGH Open       Date:  2020-02-12

Review 4.  New treatments for irritable bowel syndrome in women.

Authors:  Mopelola A Adeyemo; Lin Chang
Journal:  Womens Health (Lond)       Date:  2008-11

5.  Irritable bowel syndrome: diagnosis and pathogenesis.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

6.  Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention.

Authors:  J Labus; A Gupta; H K Gill; I Posserud; M Mayer; H Raeen; R Bolus; M Simren; B D Naliboff; E A Mayer
Journal:  Aliment Pharmacol Ther       Date:  2012-12-03       Impact factor: 8.171

Review 7.  Diet in irritable bowel syndrome.

Authors:  Magdy El-Salhy; Doris Gundersen
Journal:  Nutr J       Date:  2015-04-14       Impact factor: 3.271

8.  Association between self-reported vegetarian diet and the irritable bowel syndrome in the French NutriNet cohort.

Authors:  Camille Buscail; Jean-Marc Sabate; Michel Bouchoucha; Marion J Torres; Benjamin Allès; Serge Hercberg; Robert Benamouzig; Chantal Julia
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

9.  The Effect of Tong-Xie-Yao-Fang on Intestinal Mucosal Mast Cells in Postinfectious Irritable Bowel Syndrome Rats.

Authors:  Xiangxue Ma; Xiaoge Wang; Nan Kang; Ting Chen; Haijie Ji; Lin Lv; Xiaolan Yin; Yaxin Tian; Rui Zheng; Yuanzhi Duan; Fengyun Wang; Xudong Tang
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-26       Impact factor: 2.629

Review 10.  Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review).

Authors:  Magdy El-Salhy; Odd Helge Gilja; Doris Gundersen; Jan G Hatlebakk; Trygve Hausken
Journal:  Int J Mol Med       Date:  2014-06-17       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.